Document ID: EPA-HQ-OW-2003-0007-0012
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2003-03-13T05:00Z

Effluent
Limitations
Guidelines,
Pretreatment
Standards,
and
New
Source
Performance
Standards
for
the
Pharmaceutical
Manufacturing
Point
Source
Category;
Direct
Final
Rule
and
Proposed
Rule.
Federal
Register.
March
13,
2003
Vol.
68
No,
49
p.
12266
A.
Federal
Register
Notice
B.
Other
Federal
Registers
C.
Selected
References
D.
Public
Comments
1.
Comments
Received
Postmarked
On
or
Before
May
12,
2003
2.
Comments
Received
Postmarked
After
May
12,
2003
OW­
2003­
0007
A.
1
A.
Federal
Register
1.
Effluent
Limitations
Guidelines,
Pretreatment
Standards,
and
New
Source
Performance
Standards
for
the
Pharmaceutical
Manufacturing
Point
Source
Category;
Direct
Final
Rule.
Federal
Register.
Vol.
68
No,
49
March
13,
2003
p.
12266
11
pp.

2.
Effluent
Limitations
Guidelines,
Pretreatment
Standards,
and
New
Source
Performance
Standards
for
the
Pharmaceutical
Manufacturing
Point
Source
Category;
Proposed
Rule.
Federal
Register.
Vol.
68
No.
49
March
13,
2003.
p.
12276
11
pp.
OW­
2002­
0007
B.

Other
Federal
Registers
1.
Pharmaceutical
Manufacturing
Point
Source
Category.
Interim
Final
Rulemaking.
Vol.
41,
No.
223;
November
17,
1976
11
pp.

2.
Pharmaceutical
Manufacturing
Point
Source
Category
Effluent
Limitations
Guidelines,
Pretreatment
Standards,
and
New
Source
Performance
Standards;
Final
Rule
Vol.
48
No
209
October
27,
1983,
27
pp.

3.
Pharmaceutical
Manufacturing
Point
Source
Category
Effluent
Limitations
Guidelines,
Pretreatment
Standards,
and
New
Source
Performance
Standards;
Proposed
Rule
Vol.
48
No
209
October
27,
1983,
27
pp.

4.
Pharmaceutical
Manufacturing
Point
Source
Category
Effluent
Limitations
Guidelines,
Pretreatment
Standards,
and
New
Source
Performance
Standards;
Final
Rule.
Vol.
63
No
182
September
21,
1998
p.
50388.

5.
Pharmaceutical
Manufacturing
Point
Source
Category
Effluent
Limitations
Guidelines,
Pretreatment
Standards,
and
New
Source
Performance
Standards;
Correcting
amendments.
Vol.
54,
No
170,
September
5,
1999
p.
48103
­
48104.
2
pp.

6.
Pharmaceutical
Manufacturing
Point
Source
Category
Effluent
Limitations
Guidelines,
Pretreatment
Standards,
and
New
Source
Performance
Standards;
Final
Rule.
Vol.
64,
No
42.
March
4,
1996.
P.
10391­
10394
4
pp
7.
Pharmaceutical
Manufacturing
Point
Source
Category
Effluent
Limitations
Guidelines,
Pretreatment
Standards,
and
New
Source
Performance
Standards;
Final
Rule.
Correction
Notice.
Vol.
64
No
50
March
16,
1999.
p.
13053
OW­
2003­
0007
C.

C.
Other
References
1.
Copy
of
1998
Rulelmaking
Record
Iondex
for
Pharmaceutical
Manufacturing
Point
Source
Category.
79
pp.

2.
40
CFR
Part
439.
Pharmaceutical
Manufacturing
Point
Source
Category.
28
pp.

3.
Johanson,
G.
and
B.
Dynesius.
Liquid/
air
partition
coefficients
of
six
commonly
used
glycol
ethers.
British
Journal
of
Industrial
Medicine
1988,
45:
561­
564.
4
pp.